QOP
ANGO icon

Quinn Opportunity Partners’s AngioDynamics ANGO Stock Holding History

Quinn Opportunity Partners’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,000
Closed -$114K – 365
2026
Q1 		$114K Hold
10,000
– – 0.01% 342
2025
Q4 		$128K Hold
10,000
– – 0.01% 344
2025
Q3 		$112K Hold
10,000
– – 0.01% 301
2025
Q2 		$99.2K Hold
10,000
– – 0.01% 321
2025
Q1 		$93.9K Hold
10,000
– – 0.01% 369
2024
Q4 		$91.6K Buy
+10,000
New +$73.5K 0.01% 361

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quinn Opportunity Partners's ANGO Position: Q2 2026 in Review

Quinn Opportunity Partners sold out of AngioDynamics (ANGO) in Q2 2026, closing a stake of 10,000 shares — an estimated $114K sold.

Quinn Opportunity Partners first reported a position in ANGO in Q4 2024 and held it in 6 quarters. The position peaked at $128K in Q4 2025. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Quinn Opportunity Partners reported no remaining AngioDynamics position as of Q2 2026 after selling out during the quarter.
  • Quinn Opportunity Partners sold 10,000 AngioDynamics shares in Q2 2026, an estimated $114K.
  • Quinn Opportunity Partners first reported a position in AngioDynamics in Q4 2024 and held it in 6 quarters.
  • Quinn Opportunity Partners's AngioDynamics position peaked at $128K in Q4 2025.
  • 161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Quinn Opportunity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.